Cargando…
Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants
The tumour necrosis factor family member TNF-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in a variety of cancer cells through the activation of death receptors 4 (DR4) and 5 (DR5) and is considered a promising anticancer therapeutic agent. As apoptosis seems to occur prim...
Autores principales: | Reis, C R, van der Sloot, A M, Natoni, A, Szegezdi, E, Setroikromo, R, Meijer, M, Sjollema, K, Stricher, F, Cool, R H, Samali, A, Serrano, L, Quax, W J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035906/ https://www.ncbi.nlm.nih.gov/pubmed/21368856 http://dx.doi.org/10.1038/cddis.2010.61 |
Ejemplares similares
-
Targeting AML through DR4 with a novel variant of rhTRAIL
por: Szegezdi, Eva, et al.
Publicado: (2011) -
Kinetics in Signal Transduction Pathways Involving Promiscuous Oligomerizing Receptors Can Be Determined by Receptor Specificity: Apoptosis Induction by TRAIL
por: Szegezdi, Eva, et al.
Publicado: (2012) -
Death Receptor 5 Displayed on Extracellular Vesicles Decreases TRAIL Sensitivity of Colon Cancer Cells
por: Setroikromo, Rita, et al.
Publicado: (2020) -
Three on Three: Universal
and High-Affinity Molecular
Recognition of the Symmetric Homotrimeric Spike Protein of SARS-CoV-2
with a Symmetric Homotrimeric Aptamer
por: Li, Jiuxing, et al.
Publicado: (2022) -
TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt
por: Szegezdi, E, et al.
Publicado: (2006)